CYTOKINETICS INC — Director's Dealing 2021

Mar 10, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2021-03-08

Reporting Person: Wong Robert (VP, Chief Accounting Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-08	Common Stock	F	1359	$19.19	Disposed	23879	Direct

Footnotes

F1: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on 03/06/2021 and does not represent a sale by the reporting person.

F2: Includes up to 5,238 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan.